Chaperoning tumour antigens into the immune system. 1996

C Featherstone

UI MeSH Term Description Entries
D006360 Heat-Shock Proteins Proteins which are synthesized in eukaryotic organisms and bacteria in response to hyperthermia and other environmental stresses. They increase thermal tolerance and perform functions essential to cell survival under these conditions. Stress Protein,Stress Proteins,Heat-Shock Protein,Heat Shock Protein,Heat Shock Proteins,Protein, Stress
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000951 Antigens, Neoplasm Proteins, glycoprotein, or lipoprotein moieties on surfaces of tumor cells that are usually identified by monoclonal antibodies. Many of these are of either embryonic or viral origin. Neoplasm Antigens,Tumor Antigen,Tumor Antigens,Antigen, Tumor,Antigens, Tumor
D019496 Cancer Vaccines Vaccines or candidate vaccines designed to prevent or treat cancer. Vaccines are produced using the patient's own whole tumor cells as the source of antigens, or using tumor-specific antigens, often recombinantly produced. Cancer Vaccine,Neoplasm Vaccines,Tumor Vaccine,Tumor Vaccines,Vaccines, Cancer,Vaccines, Neoplasm,Vaccines, Tumor,Vaccine, Cancer,Vaccine, Tumor

Related Publications

C Featherstone
January 2011, Biochemical Society transactions,
C Featherstone
September 1977, Transactions of the ophthalmological societies of the United Kingdom,
C Featherstone
January 1977, Annales d'immunologie,
C Featherstone
April 2010, Progress in lipid research,
C Featherstone
December 1971, British medical journal,
C Featherstone
September 2002, Immunology,
C Featherstone
January 1991, Acta oto-laryngologica,
C Featherstone
January 1969, Proceedings. Canadian Cancer Conference,
C Featherstone
January 1976, Biochemical Society transactions,
Copied contents to your clipboard!